Cutting-edge research on postbiotic formulations (e.g., MS-20) demonstrates synergistic effects with PD-1 blockade, significantly enhancing CD8 + T cell infiltration and tumor control (Lee et al., 2024). This evidence concerns the gene CD8A and neoplasm.